“…In contrast, CD4 T cells, γδT cells, MAIT cells, NK cells, Tfh cells, and CD8T cells were downregulated immune cells in pancreatic cancer ( Figure 6 B,C). This suggests that EGFR, SERPINB5, MYEOV, GPRC5A, and KRAS may drive further pancreatic cancer development by recruiting pro-tumor-associated immune cells such as monocytes, nTreg cells, and Th17 cells through downstream responses while inhibiting the infiltration of tumor-suppressive immune cells such as CD4 T cells, γδT cells, MAIT cells, NK cells, Tfh cells, and CD8T cells to reduce tumor-associated immune killing [ 19 , 20 , 21 , 22 ]. All these results further corroborate and explain our speculation about the role of the molecular network of MYEOV-related genes for pancreatic cancer.…”